Cardiomyopathy, Hypertrophic
"Cardiomyopathy, Hypertrophic" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A form of CARDIAC MUSCLE disease, characterized by left and/or right ventricular hypertrophy (HYPERTROPHY, LEFT VENTRICULAR; HYPERTROPHY, RIGHT VENTRICULAR), frequent asymmetrical involvement of the HEART SEPTUM, and normal or reduced left ventricular volume. Risk factors include HYPERTENSION; AORTIC STENOSIS; and gene MUTATION; (FAMILIAL HYPERTROPHIC CARDIOMYOPATHY).
Descriptor ID |
D002312
|
MeSH Number(s) |
C14.280.238.100 C14.280.484.150.070.160
|
Concept/Terms |
Cardiomyopathy, Hypertrophic- Cardiomyopathy, Hypertrophic
- Cardiomyopathies, Hypertrophic
- Hypertrophic Cardiomyopathies
- Hypertrophic Cardiomyopathy
- Cardiomyopathy, Hypertrophic Obstructive
- Cardiomyopathies, Hypertrophic Obstructive
- Hypertrophic Obstructive Cardiomyopathies
- Hypertrophic Obstructive Cardiomyopathy
- Obstructive Cardiomyopathies, Hypertrophic
- Obstructive Cardiomyopathy, Hypertrophic
|
Below are MeSH descriptors whose meaning is more general than "Cardiomyopathy, Hypertrophic".
Below are MeSH descriptors whose meaning is more specific than "Cardiomyopathy, Hypertrophic".
This graph shows the total number of publications written about "Cardiomyopathy, Hypertrophic" by people in this website by year, and whether "Cardiomyopathy, Hypertrophic" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
Year | Major Topic | Minor Topic | Total |
---|
1995 | 1 | 0 | 1 |
1997 | 3 | 0 | 3 |
1998 | 2 | 1 | 3 |
1999 | 3 | 0 | 3 |
2000 | 2 | 0 | 2 |
2001 | 3 | 0 | 3 |
2002 | 0 | 1 | 1 |
2003 | 1 | 1 | 2 |
2004 | 4 | 1 | 5 |
2005 | 3 | 0 | 3 |
2006 | 1 | 0 | 1 |
2007 | 4 | 0 | 4 |
2008 | 3 | 1 | 4 |
2009 | 5 | 0 | 5 |
2010 | 5 | 1 | 6 |
2011 | 2 | 1 | 3 |
2012 | 5 | 1 | 6 |
2013 | 2 | 0 | 2 |
2014 | 1 | 0 | 1 |
2015 | 2 | 0 | 2 |
2016 | 4 | 2 | 6 |
2017 | 3 | 1 | 4 |
2018 | 2 | 0 | 2 |
2019 | 5 | 2 | 7 |
2020 | 8 | 0 | 8 |
2021 | 6 | 0 | 6 |
2022 | 5 | 1 | 6 |
2023 | 6 | 0 | 6 |
2024 | 3 | 0 | 3 |
To return to the timeline,
click here.
Below are the most recent publications written about "Cardiomyopathy, Hypertrophic" by people in Profiles.
-
Myocardial Scarring and Sudden Cardiac Death in Young Patients With Hypertrophic Cardiomyopathy: A Multicenter Cohort Study. JAMA Cardiol. 2024 Nov 01; 9(11):1001-1008.
-
Hypertrophic cardiomyopathy and competitive sports: let 'em play? Curr Opin Cardiol. 2024 Jul 01; 39(4):308-314.
-
2024 AHA/ACC/AMSSM/HRS/PACES/SCMR Guideline for the Management of Hypertrophic Cardiomyopathy: A Report of the American Heart Association/American College of Cardiology Joint Committee on Clinical Practice Guidelines. J Am Coll Cardiol. 2024 Jun 11; 83(23):2324-2405.
-
Modeling the Relationship Between Diastolic Phenotype and Outcomes in Pediatric Hypertrophic Cardiomyopathy. J Am Soc Echocardiogr. 2024 May; 37(5):508-517.e3.
-
Perioperative outcomes of hypertrophic cardiomyopathy: An insight from the National Readmission Database. Int J Cardiol. 2024 Mar 01; 398:131601.
-
Vigorous Exercise in Patients With Hypertrophic Cardiomyopathy. JAMA Cardiol. 2023 06 01; 8(6):595-605.
-
Septal Myectomy Outcomes in Children and Adolescents With Obstructive Hypertrophic Cardiomyopathy. Ann Thorac Surg. 2023 09; 116(3):499-507.
-
Risk of Sudden Death in Patients?With?RASopathy Hypertrophic?Cardiomyopathy. J Am Coll Cardiol. 2023 03 21; 81(11):1035-1045.
-
Myosin Inhibitors: The Next Generation. J Am Coll Cardiol. 2023 01 03; 81(1):46-48.
-
The Prevalence and Association of Exercise Test Abnormalities With Sudden Cardiac Death and Transplant-Free Survival in Childhood Hypertrophic Cardiomyopathy. Circulation. 2023 02 28; 147(9):718-727.